Coagulopathy in CAR‐T: Critical concern or mere blip?

Documenti analoghi

• Predicting therapy‐related myeloid neoplasms after CAR‐T with the Clonal Haematopoiesis Risk Score (CHRS)
  di: Eugenio Galli, et al.
  Pubblicazione: (2024)
• Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T
  di: Eugenio Galli, et al.
  Pubblicazione: (2025)
• The CAR T‐cell race: The rules of the game
  di: Adriana Balduzzi
  Pubblicazione: (2024)
• Are we there yet? CAR ‐T therapy in multiple myeloma
  di: Eitan Mirvis, et al.
  Pubblicazione: (2024)
• CCR5 predicts neurotoxicity in CAR‐T‐cell therapy
  di: Ayal Rozenberg, et al.
  Pubblicazione: (2025)